Version 1
: Received: 9 November 2022 / Approved: 14 November 2022 / Online: 14 November 2022 (01:06:35 CET)
How to cite:
Manrique J., E.Y.; Duran-Lengua, M.; Ballesteros, A. Incompatibilities and Interactions Drugs-Artificial Enteral Nutrition in a Hospital Institution in Cartagena/Colombia. Preprints2022, 2022110224. https://doi.org/10.20944/preprints202211.0224.v1
Manrique J., E.Y.; Duran-Lengua, M.; Ballesteros, A. Incompatibilities and Interactions Drugs-Artificial Enteral Nutrition in a Hospital Institution in Cartagena/Colombia. Preprints 2022, 2022110224. https://doi.org/10.20944/preprints202211.0224.v1
Manrique J., E.Y.; Duran-Lengua, M.; Ballesteros, A. Incompatibilities and Interactions Drugs-Artificial Enteral Nutrition in a Hospital Institution in Cartagena/Colombia. Preprints2022, 2022110224. https://doi.org/10.20944/preprints202211.0224.v1
APA Style
Manrique J., E.Y., Duran-Lengua, M., & Ballesteros, A. (2022). Incompatibilities and Interactions Drugs-Artificial Enteral Nutrition in a Hospital Institution in Cartagena/Colombia. Preprints. https://doi.org/10.20944/preprints202211.0224.v1
Chicago/Turabian Style
Manrique J., E.Y., Marlene Duran-Lengua and Andres Ballesteros. 2022 "Incompatibilities and Interactions Drugs-Artificial Enteral Nutrition in a Hospital Institution in Cartagena/Colombia" Preprints. https://doi.org/10.20944/preprints202211.0224.v1
Abstract
Artificial enteral nutrition (AEN) is defined as the delivery of nutrients through feeding tubes for special medical purposes. Patients usually suffer from chronic or critical illnesses and are generally polymedicated, which represents a high probability of interactions and incompati-bilities with the AEN that can cause adverse events and loss of effectiveness of pharmacological treatment. This study aimed to determine the potential incompatibilities and drug-enteral nu-trition interactions in patients hospitalized in a clinic in the city of Cartagena. A retrospective cross-sectional study design was used, in a sample of 218 patients with a stay of at least three days, who were prescribed at least five medications and AEN. The data was collected from medical records. The information was screened with the CheckTheMeds software, using the APPs: drug-interactionchecker and https://www.rccc.eu/ppc/Drogas/DrogasxSNG.htm. A prevalence of pharmaceutical type incompatibilities of 50% and physicochemical type of 31.65%, interactions of pharmacokinetic type 10.55% and physiological type of 6.42% was re-vealed. The adverse events identified were tube obstruction 54.78% (n=126), mobility disorders and/or gastric emptying disorders 22.61% (n=52), diarrhea 12.51% (n=29), mesenteric ischemia with 0.87% (n=2) and seizures 6.96% (n=16). The p and OR values were variable according to the interaction and/or incompatibility vs. adverse events. Drugs-AEN incompatibilities and inter-actions were frequent, which is why active pharmacovigilance is necessary to intervene in the safety, quality and cost-effectiveness of the care provided in the different care services.
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
